Detection of emergent strains of West Nile virus with a blood screening assay

Transfusion

Volumn 56, Issue 6, 2016, Pages 1503-1507

  Faddy, Helen M ^a,b   Flower, Robert L P ^a   Seed, Clive R ^a   Ismay, Susan ^c   Ong, Edgar ^d   Linnen, Jeffrey M ^d   Cory, Robin ^d   Holmberg, Jerry A ^e   Hall, Roy A ^b   Setoh, Yin X ^b   Deerain, Joshua M ^b   Prow, Natalie A ^b,f  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Australian Red Cross Blood Service   (Australia)

^d HOLOGIC INC   (United States)

^e Grifols Diagnostic Solutions Inc   (United States)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; CASE REPORT; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; SCREENING TEST; STUDY DESIGN; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSCRIPTION; WEST NILE VIRUS; ANIMAL; BLOOD TRANSFUSION REACTION; GENETICS; HORSE; MASS SCREENING; NUCLEIC ACID AMPLIFICATION; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; STANDARDS; TRANSMISSION; WEST NILE FEVER;

ANIMALS; BLOOD DONORS; HORSES; HUMANS; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFUSION REACTION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84974555996     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13443     Document Type: Article

References (20)

1. Petersen LR, Busch MP., Transfusion-transmitted arboviruses. Vox Sang 2010; 98: 495-503.
2. Dodd RY, Foster GA, Stramer SL., Keeping blood transfusion safe from West Nile virus: American Red Cross experience, 2003 to 2012. Transfus Med Rev 2015; 29: 153-61.
3. Jerzak GV, Bernard K, Kramer LD, et al., The West Nile virus mutant spectrum is host-dependent and a determinant of mortality in mice. Virology 2007; 360: 469-76.
4. Brackney DE, Pesko KN, Brown IK, et al., West Nile virus genetic diversity is maintained during transmission by Culex pipiens quinquefasciatus mosquitoes. PLoS One 2011; 6: e24466.
5. Duggal NK, D'Anton M, Xiang J, et al., Sequence analyses of 2012 West Nile virus isolates from Texas fail to associate viral genetic factors with outbreak magnitude. Am J Trop Med Hyg 2013; 89: 205-10.
6. Frost MJ, Zhang J, Edmonds JH, et al., Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg Infect Dis 2012; 18: 792-800.
7. van den Hurk AF, Hall-Mendelin S, Webb CE, et al., Role of enhanced vector transmission of a new West Nile virus strain in an outbreak of equine disease in Australia in 2011. Parasit Vectors 2014; 7: 586.
8. May FJ, Davis CT, Tesh RB, et al., Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol 2011; 85: 2964-74.
9. Prow NA., The changing epidemiology of Kunjin virus in Australia. Int J Environ Res Public Health 2013; 10: 6255-72.
10. Knope KE, Doggett SL, Kurucz N, et al., Arboviral diseases and malaria in Australia, 2011-12: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell Q Rep 2014; 38: E122-42.
11. Prow NA, Hewlett EK, Faddy HM, et al., The Australian public is still vulnerable to emerging virulent strains of West Nile virus. Front Public Health 2014; 2: 146.
12. Jansen CC, Ritchie SA, van den Hurk AF., The role of Australian mosquito species in the transmission of endemic and exotic West Nile virus strains. Int J Environ Res Public Health 2013; 10: 3735-52.
13. Lanteri MC, Lee TH, Wen L, et al., West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion 2014; 54: 3232-41.
14. Linnen JM, Deras ML, Cline J, et al., Performance evaluation of the PROCLEIX West Nile virus assay on semi-automated and automated systems. J Med Virol 2007; 79: 1422-30.
15. Gaibani P, Pierro AM, Cavrini F, et al., False-positive transcription-mediated amplification assay detection of West Nile virus in blood from a patient with viremia caused by an Usutu virus infection. J Clin Microbiol 2010; 48: 3338-9.
16. Schmidt M, Korn K, Nübling CM, et al., First transmission of human immunodeficiency virus type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion 2009; 49: 1836-44.
17. Chudy M, Kress J, Halbauer J, et al., Risk minimization measures for blood screening HIV-1 nucleic acid amplification technique assays in Germany. Transfus Med Hemother 2014; 41: 45-51.
18. Mohr H, Steil L, Gravemann U, et al., A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009; 49: 2612-24.
19. Ruane PH, Edrich R, Gampp D, et al., Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44: 877-85.
20. Lin L, Hanson CV, Alter HJ, et al., Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005; 45: 580-90.